Purification and characterization of hypoxia-inducible factor 1
- PMID: 7836384
- DOI: 10.1074/jbc.270.3.1230
Purification and characterization of hypoxia-inducible factor 1
Abstract
Hypoxia-inducible factor 1 (HIF-1) is a DNA-binding protein that activates erythropoietin (Epo) gene transcription in Hep3B cells subjected to hypoxia or cobalt chloride treatment. HIF-1 DNA binding activity is also induced by hypoxia or cobalt in non-Epo-producing cells, suggesting a general role for HIF-1 in hypoxia signal transduction and transcriptional regulation. Here we report the biochemical purification of HIF-1 from Epo-producing Hep3B cells and non-Epo-producing HeLa S3 cells. HIF-1 protein was purified 11,250-fold by DEAE ion-exchange and DNA affinity chromatography. Analysis of HIF-1 isolated from a preparative gel shift assay revealed four polypeptides. Peptide mapping of these HIF-1 components demonstrated that 91-, 93-, and 94-kDa polypeptides had similar tryptic maps, whereas the 120-kDa polypeptide had a distinct profile. Glycerol gradient sedimentation analysis suggested that HIF-1 exists predominantly in a heterodimeric form and to a lesser extent as a heterotetramer. Partially purified HIF-1 bound specifically to the wild-type HIF-1 binding site from the EPO enhancer but not to a mutant sequence that lacks hypoxia-inducible enhancer activity. UV cross-linking analysis with purified HIF-1 indicated that both subunits of HIF-1 contact DNA directly. We conclude that in both cobalt chloride-treated HeLa cells and hypoxic Hep3B cells HIF-1 is composed of two different subunits: 120-kDa HIF-1 alpha and 91-94-kDa HIF-1 beta.
Similar articles
-
Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction.Blood. 1993 Dec 15;82(12):3610-5. Blood. 1993. PMID: 8260699
-
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.Proc Natl Acad Sci U S A. 1993 May 1;90(9):4304-8. doi: 10.1073/pnas.90.9.4304. Proc Natl Acad Sci U S A. 1993. PMID: 8387214 Free PMC article.
-
Co-transactivation of the 3' erythropoietin hypoxia inducible enhancer by the HIF-1 protein.Blood Cells Mol Dis. 1997 Aug;23(2):169-76. doi: 10.1006/bcmd.1997.0134. Blood Cells Mol Dis. 1997. PMID: 9236155
-
Erythropoietin gene regulation depends on heme-dependent oxygen sensing and assembly of interacting transcription factors.Kidney Int. 1997 Feb;51(2):548-52. doi: 10.1038/ki.1997.76. Kidney Int. 1997. PMID: 9027736 Review.
-
Structural and functional analysis of hypoxia-inducible factor 1.Kidney Int. 1997 Feb;51(2):553-5. doi: 10.1038/ki.1997.77. Kidney Int. 1997. PMID: 9027737 Review.
Cited by
-
Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells.Oncotarget. 2015 Jun 30;6(18):16031-42. doi: 10.18632/oncotarget.3648. Oncotarget. 2015. PMID: 26202747 Free PMC article.
-
Midkine Is a Potential Therapeutic Target of Tumorigenesis, Angiogenesis, and Metastasis in Non-Small Cell Lung Cancer.Cancers (Basel). 2020 Aug 24;12(9):2402. doi: 10.3390/cancers12092402. Cancers (Basel). 2020. PMID: 32847073 Free PMC article.
-
Emerging Roles of Inhibitor of Differentiation-1 in Alzheimer's Disease: Cell Cycle Reentry and Beyond.Cells. 2020 Jul 21;9(7):1746. doi: 10.3390/cells9071746. Cells. 2020. PMID: 32708313 Free PMC article. Review.
-
Cartilage Homeostasis under Physioxia.Int J Mol Sci. 2024 Aug 29;25(17):9398. doi: 10.3390/ijms25179398. Int J Mol Sci. 2024. PMID: 39273346 Free PMC article. Review.
-
Direct inhibition of tumor hypoxia response with synthetic transcriptional repressors.Nat Chem Biol. 2024 Aug 30. doi: 10.1038/s41589-024-01716-z. Online ahead of print. Nat Chem Biol. 2024. PMID: 39215099
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials